4th Circ. Backs Toss Of FCA Medicaid Suit Against Allergan
A split Fourth Circuit panel has refused to revive a False Claims Act suit alleging an Allergan unit fraudulently reported drug prices to Medicaid and cost the federal government at least...To view the full article, register now.
Already a subscriber? Click here to view full article